IL-1 BINDING PROTEINS
    4.
    发明申请
    IL-1 BINDING PROTEINS 审中-公开
    IL-1结合蛋白

    公开(公告)号:US20130295004A1

    公开(公告)日:2013-11-07

    申请号:US13775540

    申请日:2013-02-25

    摘要: The present invention describes IL-1β binding proteins, including chimeric, CDR-grafted, and humanized antibodies that bind IL-1β. Binding proteins of the invention have high affinity for IL-1β and neutralize IL-1β activity. A binding protein of the invention can be a full-length antibody or an IL-1β-binding portion thereof. Methods of making and methods of using the binding proteins of the invention are also described. The IL-1β binding proteins of the invention are useful for detecting IL-1β and for inhibiting IL-1β activity, including in a human subject suffering from a disease or disorder in which IL-1β activity is detrimental.

    摘要翻译: 本发明描述了IL-1β结合蛋白,包括结合IL-1β的嵌合,CDR移植和人源化抗体。 本发明的结合蛋白对IL-1β具有高亲和力并中和IL-1β活性。 本发明的结合蛋白可以是全长抗体或其IL-1beta结合部分。 还描述了制备方法和使用本发明的结合蛋白的方法。 本发明的IL-1β结合蛋白可用于检测IL-1β和抑制IL-1β活性,包括在患有IL-1β活性有害的疾病或病症的人类受试者中。

    IL-1 binding proteins
    5.
    发明授权
    IL-1 binding proteins 有权
    IL-1结合蛋白

    公开(公告)号:US08398966B2

    公开(公告)日:2013-03-19

    申请号:US12905499

    申请日:2010-10-15

    IPC分类号: A61K39/395 C07K16/24

    摘要: The present invention describes IL-1β binding proteins, including chimeric, CDR-grafted, and humanized antibodies that bind IL-1β. Binding proteins of the invention have high affinity for IL-1β and neutralize IL-1β activity. A binding protein of the invention can be a full-length antibody or an IL-1β-binding portion thereof. Methods of making and methods of using the binding proteins of the invention are also described. The IL-1β binding proteins of the invention are useful for detecting IL-1β and for inhibiting IL-1β activity, including in a human subject suffering from a disease or disorder in which IL-1β activity is detrimental.

    摘要翻译: 本发明描述了IL-1和bgr 结合蛋白,包括结合IL-1和bgr的嵌合,CDR移植和人源化抗体。 本发明的结合蛋白对IL-1和bgr具有高亲和力; 并中和IL-1和bgr; 活动。 本发明的结合蛋白可以是全长抗体或其IL-1结合部分。 还描述了制备方法和使用本发明的结合蛋白的方法。 IL-1和bgr 本发明的结合蛋白质可用于检测IL-1和bgr; 并用于抑制IL-1和bgr; 活动,包括在患有IL-1和bgr的疾病或病症的人类受试者中。 活动是有害的。